ThermoFisher Scientific Orbitrap Eclipse with ETD and UVPD
ThermoFisher Scientific Orbitrap Eclipse with ETD and UVPD
批准号:
10427682
负责人:
Miklos Guttman
金额:
$118.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2023-08-31
关键词:
AddressAreaBiologicalBiomedical ResearchComplexDevelopmentDissociationElectron TransportFundingFutureGlycobiologyGlycopeptidesMass Spectrum AnalysisMethodsPharmacy SchoolsPolysaccharidesPost-Translational Protein ProcessingProtein AnalysisProteinsProteomicsRefractoryResearchResolutionSamplingSiteSourceSystemTimeUnited States National Institutes of HealthUniversitiesVirionWashingtondetection limitglycoproteomicsinstrumentinstrumentationmass spectrometernovelprotein complextoolultraviolet
中文摘要
项目概要:
这项修订后的提案寻求资金,以获得一个热轨道阱日食质谱仪
配备ETD和UVPD,以满足HDX-MS和糖蛋白组学研究的关键需求,
华盛顿大学。这个系统将使我们的团队能够克服技术限制,
和样本分析瓶颈,阻碍和停滞了许多NIH资助的项目。讣告
Eclipse平台是扩展我们的项目范围和吞吐量的最合适的平台。
HDX-MS研究:1)提供最先进的灵敏度,检测下限,使HDX-
MS研究非常有限的材料样本,包括完整的病毒颗粒和难以纯化的蛋白质
2)达到500,000的质量分辨率,这是天然生物来源的10倍。
可在我们现有的仪器上获得,并且是分析高度复杂样品所必需的; 3)
能够进行常规和稳健的高通量电子转移解离(ETD),这对于
复杂蛋白质样品和糖肽的鉴定; 4)紫外线吸收
光解离(UVPD),用于扩大HDX-MS研究可获得的分辨率;和5)
能够通过ETD和UVPD对经典难治性蛋白质进行自上而下的HDX-MS研究
自下而上的方法。在迅速的时间范围内将联合收割机不同的破碎方法结合起来的能力将
能够开发用于位点特异性糖蛋白质组学研究的新工具,
糖生物学的聚糖结构解析所需的工具。这一工具,以其广泛的
能力,也将有利于一般蛋白质组学的应用和鉴定罕见的和新的后,
翻译修饰虽然有几个质谱仪可在华盛顿大学,所有的高端
系统被大量利用并专用于其它应用。HDX-MS系统是
我们的大多数用户都住在药学院质谱中心,不能
移动并与设施外的仪器连接。此外,没有一个单一的
UVPD使高分辨率质谱仪在华盛顿大学或任何地方在更大的西雅图地区,
满足当前的技术需求。这一共同工具将提供能力和途径,
需要推进目前NIH资助的研究,并将使我们能够推动蛋白质的边界
HDX-MS分析和生物医学研究中的位点特异性糖蛋白质组学研究,以支持未来
NIH资助的项目。
英文摘要
Project summary:
This revised proposal seeks funds to acquire a Thermo Orbitrap Eclipse mass spectrometer
equipped with ETD and UVPD to address critical needs for HDX-MS and glycoproteomics studies at
the University of Washington. This system would allow our groups to overcome the technical limitations
and sample analysis bottlenecks that have hindered and stalled many NIH funded projects. The Obitrap
Eclipse platform is the most suitable platform for expanding the projects scopes and throughput of our
HDX-MS studies as it: 1) Offers state of the art sensitivity to lower limits of detection to enable HDX-
MS studies of very material-limited samples, including intact virus particles and hard to purify proteins
from native biological sources; 2) Achieves a mass resolution of 500,000 which is ten times higher than
obtainable on our current instrumentation and is necessary for analyzing highly complex samples; 3) Is
capable of routine and robust high-throughput electron transfer dissociation (ETD), which is vital for
identification of complex protein samples and glycopeptides; 4) Incorporates ultra-violet
photodissociation (UVPD) for expanding the resolution obtainable from HDX-MS studies; and 5)
Enables top-down HDX-MS studies through both ETD and UVPD for proteins refractory to classical
bottom-up approaches. The capacity to combine different fragmentation methods a rapid timescale will
enable development of new tools for site-specific glycoproteomics studies and development of much
needed tools for glycan structural elucidation for glycobiology. This instrument, with its broad
capabilities, will also benefit general proteomics applications and identification of rare and novel post-
translational modifications. While several mass spectrometers are available at UW, all the high-end
systems are heavily utilized and devoted to other applications. The HDX-MS system that is required for
the majority of our users is housed in the School of Pharmacy Mass Spectrometry Center and cannot
be moved and interfaced with the instruments outside of the facility. Additionally, there is not a single
UVPD enabled high resolution mass spectrometer at UW or anywhere in the greater Seattle area to
support out current technological needs. This shared instrument will provide the capabilities and access
needed to advance current NIH funded research and will allow us to push the boundaries of protein
analysis by HDX-MS and site-specific glycoproteomics studies in biomedical research to support future
NIH funded projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of IgM mediated activation of the complement system
-
批准号:10416077
-
项目类别:
-
资助金额:$48.44万
-
财政年份:2021
-
负责人:Miklos Guttman
-
依托单位:
Mechanisms of IgM mediated activation of the complement system
-
批准号:10296558
-
项目类别:
-
资助金额:$48.44万
-
财政年份:2021
-
负责人:Miklos Guttman
-
依托单位:
Mechanisms of IgM mediated activation of the complement system
-
批准号:10640282
-
项目类别:
-
资助金额:$48.44万
-
财政年份:2021
-
负责人:Miklos Guttman
-
依托单位:
Multistage LC-MSn for automated glycan isomer assignment of glycopeptides
-
批准号:10255170
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2021
-
负责人:Miklos Guttman
-
依托单位:
Hybrid structural mass spectrometry for rapid site-specific glycan structural elucidation
-
批准号:10186777
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2018
-
负责人:Miklos Guttman
-
依托单位:
Investigating the Architecture of HIV Envelope Glycoprotein
-
批准号:8262992
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2012
-
负责人:Miklos Guttman
-
依托单位:
Investigating the Architecture of HIV Envelope Glycoprotein
-
批准号:8432517
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2012
-
负责人:Miklos Guttman
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: